(Press-News.org) A team of researchers at the University of Pittsburgh has developed antibacterial compounds, derived from the outer coating of HIV, that could be potential treatments for drug-resistant bacterial infections and appear to avoid generating resistance. These new agents are quite small, making them inexpensive and easy to manufacture. The research was published in the June 2013 issue of the journal Antimicrobial Agents and Chemotherapy.
The first of many probable applications will likely be the chronic bacterial infections in the lungs of cystic fibrosis patients "that frequently develop resistance to all standard antibiotics, and are the leading cause of death in these patients," says senior author Ronald Montelaro.
The lead compound shows powerful antibacterial activity against clinical isolates of diverse pathogenic bacteria that are resistant to most antibiotics. These agents, called engineered cationic antimicrobial peptides (eCAPs) "may be applicable to treatment of other respiratory infections, topical infections, and systemic infections," says Montelaro.
The genesis of the new agent was basic research on HIV envelope protein structure and function, says Montelaro. As part of this research, "we identified highly conserved unique protein sequences that were predicted by computer modeling to assume structures characteristic of natural antibacterial peptides. Since antibacterial peptides specifically target and disrupt the integrity and function of bacterial membranes, we thought that these similar peptide sequences in the HIV envelope protein might contribute to toxicity and death in infected cells by altering cell membranes."
The team engineered the original HIV peptides for greater effectiveness and smaller size, the latter to reduce manufacturing expenses. The engineering involved modifying amino acid content (they contain just two different amino acids), peptide length, charge, and hydrophobicity. The current paper describes the third generation peptides. The lead agent contains just 12 amino acid residues.
"Another potential application is biodefense, where eCAPs may be used as a rapid postexposure aerosol treatment in individuals after exposure to aerosolized pathogens, where the goal of immediate treatment would be to rapidly reduce bacterial dose from a lethal to a nonlethal or subclinical level," says Montelaro.
###
A copy of the article can be found online at http://bit.ly/asmtip0613a.
Antimicrobial Agents and Chemotherapy is a publication of the American Society for Microbiology (ASM). The ASM is the largest single life science society, composed of over 39,000 scientists and health professionals. Its mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide.
HIV-derived antibacterial shows promise against drug-resistant bacteria
2013-06-19
ELSE PRESS RELEASES FROM THIS DATE:
States vary widely on success rates for minorities in drug treatment programs
2013-06-19
A University of Iowa study reveals significant disparities between minority and white clients in success rates for completing substance abuse treatment programs. Moreover, these disparities vary widely from state to state.
"Our findings suggest that for most states there's something amiss," says Stephan Arndt, Ph.D., UI professor of psychiatry and biostatistics. "There are strong racial and ethnic disparities for people in being able to complete substance abuse treatment programs successfully, and those disparities are something we need to set as targets to remove.
"On ...
Early-life air pollution linked with childhood asthma in minorities, in study
2013-06-19
A research team led by UCSF scientists has found that exposure in infancy to nitrogen dioxide (NO2), a component of motor vehicle air pollution, is strongly linked with later development of childhood asthma among African Americans and Latinos.
The researchers said their findings indicate that air pollution might, in fact, be a cause of the disease, and they called for a tightening of U.S government standards for annual exposure to NO2.
The study is reported online currently in the American Journal of Respiratory and Critical Care Medicine ahead of print publication. ...
Personality test finds some mouse lemurs shy, others bold
2013-06-19
DURHAM, N.C. -- Anyone who has ever owned a pet will tell you that it has a unique personality.
Yet only in the last 10 years has the study of animal personality started to gain ground with behavioral ecologists, said Jennifer Verdolin of the National Evolutionary Synthesis Center, in Durham, NC.
She and a colleague have now found distinct personalities in the grey mouse lemur (Microcebus murinus), the tiny, saucer-eyed primate native to the African island of Madagascar.
In a study published in the journal Primates, Verdolin gave fourteen gray mouse lemurs living ...
Printing tiny batteries
2013-06-19
Boston, Mass., June 18, 2013 – 3D printing can now be used to print lithium-ion microbatteries the size of a grain of sand. The printed microbatteries could supply electricity to tiny devices in fields from medicine to communications, including many that have lingered on lab benches for lack of a battery small enough to fit the device, yet provide enough stored energy to power them.
To make the microbatteries, a team based at Harvard University and the University of Illinois at Urbana-Champaign printed precisely interlaced stacks of tiny battery electrodes, each less ...
New drug could help AMD sufferers
2013-06-19
There is no cure for age-related macular degeneration, an eye disease that is the leading cause of vision loss and blindness in older Americans. Last year, the National Institutes of Health reported that two drugs injected into the eyes, Avastin and Lucentis, eased symptoms for sufferers, especially those in the advanced, "wet" stage of the disease, when blood vessels in the eye become swollen and leak fluids in the eye.
Yet for some AMD patients, the two drugs either don't work for long or fail to work at all. It's a dead end for treatment, or so it seemed.
Now, a ...
Academics earn street cred with TED Talks but no points from peers, IU research shows
2013-06-19
BLOOMINGTON, Ind. -- TED Talks, the most popular conference and events website in the world with over 1 billion informational videos viewed, provides academics with increased popular exposure but does nothing to boost citations of their work by peers, new research led by Indiana University has found.
In the comprehensive study of over 1,200 TED Talks videos and their presenters, lead author Cassidy R. Sugimoto, an assistant professor in IU Bloomington's Department of Information and Library Science, and a team of researchers from Great Britain and Canada, also looked ...
CAMH policy study outlines ways to reduce alcohol harms
2013-06-19
TORONTO, June 18, 2013 /CNW/ - The Centre for Addiction and Mental Health (CAMH) has released a summary report outlining policy strategies to reduce the harms related to alcohol, with a focus on the province of Ontario, Canada.
In the report titled 'Reducing Alcohol-Related Harms and Costs in Ontario: A Provincial Summary Report,' CAMH Senior Scientist Norman Giesbrecht outlines Ontario's policy strengths and provides recommendations to help decrease the $2.9 billion attributed annually to the direct and indirect costs of alcohol use in Ontario.
"While there are policy ...
Computer modeling technique goes viral at Brandeis
2013-06-19
It's not a hacker lab. At Brandeis University, sophisticated computational models and advances in graphical processing units are helping scientists understand the complex interplay between genomic data, virus structure and the formation of the virus' outer "shell" — critical for replication.
"We hope that some of what we are finding will help researchers alter virus assembly, leaving viruses unable to replicate," says post-doctoral fellow Jason Perlmutter, first author of the scientific paper describing the technique, published in the open access journal eLife.
Scientists ...
Brandeis scientist invents anti-cholesterol process
2013-06-19
Senior Brandeis research scientist Daniel Perlman has discovered a way to make phytosterol molecules from plants dispersible in beverages and foods that are consumed by humans, potentially opening the way to dramatic reductions in human cholesterol levels.
A U.S. patent (#8,460,738) on the new process and composition was issued on June 11.
Phytosterols in plants and cholesterol molecules in animals are highly similar and when both are dispersed together they are attracted to one another. When they mix in the gut of an animal, the cholesterol molecules are competitively ...
Scientists discover new details about rice blast, a deadly plant fungus
2013-06-19
MANHATTAN, Kan. -- Like a stealthy enemy, blast disease invades rice crops around the world, killing plants and cutting production of one of the most important global food sources.
Now, a study by an international team of researchers has shed light on how the rice blast fungus, Magnaporthe oryzae, invades plant tissue. The finding is a step toward learning how to control the disease, which by some estimates destroys enough rice to feed 60 million people annually.
The team, led by Barbara Valent, Kansas State University distinguished professor in plant pathology, found ...